Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab.
Goebeler
M
M
Herzog
S
S
Bröcker
E-B
EB
Zillikens
D
D
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010392:Pemphigus / Q000188:drug therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D003879:Dermatologic Agents; D000069283:Rituximab